Europe's revised BSE proposal would allow two-year exemption of marketed "medicinal" products.
This article was originally published in The Gray Sheet
Executive Summary
EUROPEAN UNION BSE RISK MATERIAL PROPOSAL WOULD ALLOW TWO-YEAR EXEMPTION for "medicinal products" already on the market to eliminate use of "specified risk materials" (SPM) for transmissible spongiform encephalopathies (including bovine SEs, often called "mad cow" disease).